Research Lab Results for pulmonary hypertension
Hsu LabPrincipal Investigator:
Steven Hsu, M.D.
Our work is focused on the translational human in vivo and ex vivo assessments of right ventric...ular (RV) function in the setting of pulmonary hypertension.Research Areas: pulmonary hypertension, exercise-induced pulmonary hypertension
Among patients with group I pulmonary arterial hypertension PAH, those with systemic-sclerosis-associated PAH (SSc-PAH) have a particularly poor prognosis and less optimal response to PAH-guided therapy. Using in vivo pressure-volume catheterization of the right ventricle, we have uncovered key deficiencies in resting and reserve RV function in the SSc-PAH group when compared to idiopathic PAH (IPAH) patients. These studies have uncovered key discoveries with regards to right ventricular-pulmonary arterial (RV-PA) coupling in PAH. In the lab, by studying myofilament function from RV endomyocardial biopsies from these same patients, we have uncovered corresponding deficiencies in myofilament contractility and calcium sensitivity as well. Ongoing work is directed towards determining the underlying mechanism of these findings, which will hopefully lead to therapeutic applications for RV failure in SSc-PAH.
Further endeavors are directed towards studying RV failure in other populations, including exercise-induced PH, PH secondary to left-heart disease, and the left ventricular assist device population. view more
James Sham LabPrincipal Investigator:
James Sham, Ph.D.
Research in the James Sham Lab focuses on pulmonary arteries. Studies include local calcium sig...naling in the pulmonary arteries and transient receptor potential (TRP) channels in pulmonary arterial smooth muscle cells. We’re also interested in calcium regulation in chronic hypoxic pulmonary hypertension. view moreResearch Areas: chronic hypoxic pulmonary hypertension, pulmonary medicine, arteries
Kass LabLab WebsitePrincipal Investigator:
David Kass, M.D.
Basic science investigations span an array of inquiries, such as understanding the basic mechan...isms underlying cardiac dyssynchrony and resynchronization in the failing heart, and beneficial influences of nitric oxide/cGMP/protein kinase G and cGMP-targeted phosphdiesterase signaling cascades on cardiac maladaptive stress remodeling. Recently, the latter has particularly focused on the role of phosphodiesterase type 5 and its pharmacologic inhibitors (e.g. sildenafi, Viagra®), on myocyte signaling cascades modulated by protein kinase G, and on the nitric oxide synthase dysregulation coupled with oxidant stress.Research Areas: pulmonary hypertension, heart disease, cardiac hypertrophy, heart failure, cardiology
The lab also conducts clinical research and is presently exploring new treatments for heart failure with a preserved ejection fraction, studying ventricular-arterial interaction and its role in adverse heart-vessel coupling in left heart failure and pulmonary hypertension, and testing new drug, device, and cell therapies for heart disease. A major theme has been with the use of advanced non-invasive and invasive catheterization-based methods to assess cardiac mechanics in patients.asive and invasive catheterization-based methods to assess cardiac mechanics in patients.
David Kass, MD, is currently the Director at the Johns Hopkins Center for Molecular Cardiobiology and a professor in cellular and molecular medicine. view more
Larissa Shimoda LabPrincipal Investigator:
Larissa Shimoda, Ph.D., M.S.
Research in the Larissa Shimoda Lab focuses on several important topics within pulmonary and cr...itical care medicine. We primarily study pulmonary arterial responses to chronic hypoxia as well as hypoxic pulmonary vasoconstriction and oxidant-mediated lung injury. Our recent research has included investigating the effects of chronic hypoxia on pulmonary circulation and the ways in which hypoxia-inducible factors impact pulmonary vascular responses to hypoxia. We have also studied vascular remodeling in patients with pulmonary hypertension. view moreResearch Areas: critical care medicine, lung injury, pulmonary medicine, lung disease, hypoxia
Pediatric Proteome CenterPrincipal Investigator:
Allen Everett, M.D.
Allen Everett, M.D., and his colleagues are identifying new biomarkers — measurable, physical s...igns — to help in identifying pediatric heart disease. Everett is the program leader at Johns Hopkins in pediatric biomarker discovery, initially in sickle cell disease and subsequently in other pediatric clinical conditions (birth injury, congenital heart disease repair, ECMO, prematurity and pulmonary hypertension). view moreResearch Areas: pediatric biomarker discovery, heart disease, pediatric cardiology
Stephen Mathai LabPrincipal Investigator:
Stephen Mathai, M.D., M.H.S.
The Stephen Mathai Lab focuses its research on pulmonary medicine. We're particularly intereste...d in scleroderma-associated pulmonary hypertension, pulmonary complications of connective tissue disease, idiopathic pulmonary fibrosis and pulmonary hypertension. view moreResearch Areas: scleroderma, pulmonary medicine, hypertension, pulmonary fibrosis, connective tissue disease